Micro Medical Solutions

George Quinoy, President and CEO is a seasoned C-suite executive with a proven track record of building and scaling commercial enterprises in the medical device and vascular space. Throughout his career, George has played a pivotal role in driving rapid and sustained expansion for renowned companies, including AVE, Medtronic, ACS/Guidant, Volcano Corp., and most recently, Provisio Medical.

He has demonstrated expertise in commercialization, strategic planning, forecasting, and product launches, building world-class sales organizations that lead to successful acquisitions by industry leaders. His leadership at Volcano Corp. helped grow the company from startup to over $400 million in annual sales, culminating in the company’s acquisition by Royal Philips in 2015.

George holds a Bachelor of Science degree in Public Relations from the University of Florida and continues to be a key influence in vascular innovation and commercialization.

Vince Burgess has been a member of our Board since November 2025. Mr. Burgess recently served as President, Chief Executive Officer and member of the board of directors of Acutus Medical, Inc., a medical device company, from October 2017 until May 2022, and previously served as a Venture Partner with OrbiMed Advisors, LLC, a healthcare investment firm, from September 2011 until May 2020. Previously, Mr. Burgess was a member of the initial executive team at Volcano Corporation, where he served as President of Advanced Imaging Systems. He also led marketing and business development at Volcano from 2002 to 2010. He currently serves as a member of the board of directors of Tela Bio, Inc. and has previously served on the boards of Bolt Medical, NeuroPace, Inc., Sonendo Inc., Keystone Heart, Inc., Vessix Vasular, Cryterion Medical and CardiAQ, Inc. He earned his Bachelor of Science degree in Business Administration from the University of Southern California and his Masters of Business Administration from the University of California, Los Angeles.

John Dahldorf joined Q’apel Medical, Inc. on March 31, 2025 as Chief Financial Officer. He previously was the CFO of Digirad Corporation, Volcano Corporation, Acutus Medical, SCN Bestco and Adagio Medical Holdings. He has more than 25 years of experience leading finance and accounting functions in public and private healthcare companies and currently serves on the Board of Directors of Hyperfine, Inc. John holds a Bachelors degree in Finance and a MBA from Western Illinois University.

John Fletcher founded Fletcher Spaght in 1983 and remains active as the Managing Director Emeritus. FSI has been unique in applying analytic rigor coupled with operational expertise to a broad range of clients, portfolio companies and the investment community. John has particular interests in devices, specifically in cardiology, cardiac surgery, and orthopedics, as well as in biopharma and healthcare IT.

Prior to founding Fletcher Spaght, John was a Senior Manager at The Boston Consulting Group, advising a broad range of companies in healthcare and high technology industries.

John currently serves as the Chairman of the Board of Directors for ClearPoint Neuro, Koru Medical, and Metabolon. Previously, he served as Chairman of Spectranetics during its turnaround and subsequent sale to Philips N.V. For this work as well as his work on the board of Axcelis Corporation, he was selected as Director of the Year by the National Association of Corporate Directors. He is Chairman Emeritus of the Corporate Collaboration Council at the Thayer School of Engineering/Tuck School of Business at Dartmouth College and serves on the Board of Advisors of Beth Israel Deaconess Medical Center and the Whitehead Institute at MIT.

John received his MBA from Southern Illinois University, a Master’s degree in International Finance from Central Michigan University, and a BBA in Marketing from George Washington University. He was an Instructor for courses in international business and a PhD Candidate at the Wharton School of the University of Pennsylvania. He served as a Captain and jet pilot in the U.S. Air Force and continues to be active in aviation.

Dr. Ronald Solar received his Ph.D. in Biomaterials and Materials Science from the University of Pennsylvania, and has been designing and developing medical devices for over 45 years. He co-founded several successful medical device companies, including Y Med (sold to CR Bard), X Technologies (sold to Guidant), Pameda/Occam (sold to Cordis) and Versaflex (sold to Medtronic). Dr. Solar also played key leadership and development roles for Edwards, Advanced Cardiovascular Systems, SciMed and Medtronic, and he currently holds over 68 US patents.

In 1989, Dr. Solar was recognized by President George H. W. Bush as one of the Ten Outstanding Young Americans, and Junior Chamber International (JCI) selected him as one of the Ten Outstanding Young People of the World for his contributions in medical innovation. He is a Fellow of the European Society of Cardiology and his current research interests include peripheral, neuro and cardiovascular disease, vascular injury, local drug delivery, and selective hypothermia to treat stroke and other cerebral ischemic disorders.